Treatment for Rare Blood Disorder Provides Hope for the Future

Treatment for Rare Blood Disorder Provides Hope for the Future

Dipak from Nepal has always been passionate about music. Ever since he was young, he dreamed of creating songs, performing, and making people happy through his art.

“It’s not just a hobby, it is who I am,” he said.

Then, he was diagnosed with two rare and debilitating blood disorders – aplastic anemia, where bone marrow stops producing enough red blood cells, and paroxysmal nocturnal hemoglobinuria (PNH), which causes red blood cells to break apart.

Dipak’s life became a cycle of hospital visits, tests, and treatments. He needed blood transfusions once a month, and sometimes every 15 days.

“My life revolved around my illness,” he said. “I was constantly exhausted, physically weak, and emotionally drained. Instead of building my music career, I spent my days wondering when I would need my next transfusion.”

One day, his doctor told him about a new medication that could help. At the end of 2024, The Max Foundation expanded its partnership with Novartis to include access to treatment for PNH. Now, patients in Nepal are getting the care they need and physicians are receiving training that provides a framework to better understand the disease.

However, having both aplastic anemia and PNH made treatment more complex. Dipak’s case required more testing and review by the International PNH Interest Group, a professional society Max has partnered with since 2024. They’re dedicated to enhancing knowledge about PNH and improving outcomes for patients in low-resource countries.

After a thorough evaluation, Dipak was able to start treatment. Now, four months later, he has more energy and freedom than he’s had in years.

“Most importantly, I am finally able to focus on music again,” he said. “I spend my time practicing, performing, and working toward the career I had once believed was slipping away. My illness no longer defines every decision I make.”

Dipak said he’s also grateful for the support. His medical team was with him every step of the way, and they encouraged him not to lose hope.

“Today, every song I play reminds me of how far I have come. It reminds me of every doctor, every healthcare worker, every member of the Max team in Nepal, and every person who believed in me when I struggled to believe in myself,” Dipak said. “Medication didn’t just change my treatment, it changed my life. It gave me the strength to pursue my dream again, and the opportunity to live the life I had always hoped for.”

The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.

Related Articles

  • Un Paso Max: Going the Extra Mile in the Dominican Republic

    Un Paso Max: Going the Extra Mile in the Dominican Republic

    Un Paso Max, meaning “Un Paso Mas” (One More Step) is a fitting name for a group led by cancer survivors who are willing to take an extra step to help others. Un Paso Max is the name of the CML and GIST patient association in the Dominican Republic. One can trace the origins of this group to a small meeting in 2008. It only took a bit of encouragement and support on the part of The Max Foundation to unlock the passion of a handful of courageous survivors in Santo Domingo, and the seed of a patient association was planted.

  • The “Last Mile” to Treatment Access: Malick’s Story

    The “Last Mile” to Treatment Access: Malick’s Story

    The story of Malick, a 64-year-old father and cancer survivor from Senegal, whose life has been changed by gaining access to treatment through Max Access Solutions.

  • The longest surviving beneficiary of Max’s programs in Fiji.

    The longest surviving beneficiary of Max’s programs in Fiji.

    Radha Bai Chandra is a 62-year-old widow, a mother, and the longest-surviving beneficiary of Max’s programs in Fiji. Although her search for treatment was long and challenging, the second life she now has from that search is worth it. In 2005, Radha Bai noted a change in her energy levels. She was usually an active….